Download Files:
Products Details
Product Description
– Idraparinux (sodium) is a polymethylated synthetic pentasaccharide known to interact with the antithrombin III and act as anticoagulant.
Web ID
– HY-19691
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C38H55Na9O49S7
References
– [1]Dey S, Lo HJ, Wong CH. An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux. J Am Chem Soc. 2019;141(26):10309-10314. |[2]Prandoni P, Tormene D, Perlati M, Brandolin B, Spiezia L. Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders. Expert Opin Investig Drugs. 2008;17(5):773-777.
CAS Number
– 149920-56-9
Molecular Weight
– 1727.18
SMILES
– O=[S](O[C@H]([C@H]1O[S](=O)(O[Na])=O)[C@@H]([C@H](O[C@@H]1O[C@H]([C@@H](O[C@H]2O[C@H]([C@H](O[C@@H]3OC)CO[S](=O)(O[Na])=O)[C@@H]([C@H]3O[S](=O)(O[Na])=O)O[S](=O)(O[Na])=O)C(O[Na])=O)[C@@H]([C@H]2OC)OC)CO[S](=O)(O[Na])=O)O[C@H](O[C@@H]4C(O[Na])=O)[C@@H]([C@H]([C@@H]4O[C@@H](O[C@@H]5CO[S](=O)(O[Na])=O)[C@@H]([C@H]([C@@H]5OC)OC)OC)OC)OC)(O[Na])=O
Clinical Information
– Phase 3
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Thrombin
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
